Edwards Lifesciences Corporation (EW) vs Natera, Inc. (NTRA)

A side-by-side comparison of Edwards Lifesciences Corporation and Natera, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — EW vs NTRA

growth of $100 · dividends reinvested · last 10y
EW +114.9% (+7.9%/yr)NTRA +3613.4% (+43.5%/yr)NTRA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$215$3,713
EW NTRA

EW vs NTRA: by the numbers

  • •NTRA is the larger company ($58.77B vs $49.03B market cap).
  • •EW is profitable (15.43% net margin) while NTRA runs a net loss (-7.11%).
  • •NTRA grew revenue faster over the past five years (39.92% vs 5.75% CAGR).

Metrics side by side

Valuation

MetricEWNTRA
P/E ratio48.94N/A
Forward P/E28.37N/A
PEG ratio6.91N/A
P/S ratio7.5321.71
P/B ratio4.6232.26
EV / EBITDA23.47N/A
FCF yield2.92%0.12%

Profitability

MetricEWNTRA
Gross margin77.98%65.30%
Operating margin28.09%-10.70%
Net margin15.43%-7.11%
ROE9.46%-10.56%
ROIC10.22%-13.26%

Growth (annualized)

MetricEWNTRA
Revenue CAGR (5Y)5.75%39.92%
EPS CAGR (5Y)6.87%N/A
FCF CAGR (5Y)6.41%N/A
Total return CAGR (5Y)-5.37%29.45%

Frequently asked

Which has grown faster, EW or NTRA?
Over the past five years, NTRA grew revenue faster — EW at a 5.75% CAGR versus NTRA at 39.92%.
Is EW or NTRA more profitable?
EW runs the higher net margin — EW at 15.43% versus NTRA at -7.11%.
How have EW and NTRA total returns compared?
Over the past 10 years, EW delivered 7.80% and NTRA delivered 43.39% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.